Fady Boctor - 21 Dec 2023 Form 4 Insider Report for Petros Pharmaceuticals, Inc. (PTPI)

Role
Princ. Exec. Officer & Chief Comm. Officer
Signature
/s/ Fady Boctor
Issuer symbol
PTPI
Transactions as of
21 Dec 2023
Net transactions value
$0
Form type
4
Filing time
26 Dec 2023, 17:07:49 UTC
Next filing
21 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PTPI Common Stock Award $0 +49,645 $0.000000 49,645 21 Dec 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PTPI Stock Option (Right to Buy) Award $0 +54,533 $0.000000 54,533 21 Dec 2023 Common Stock 54,533 $1.41 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options vested 50% upon the date of grant, and the remainder vests upon the achievement of certain performance goals, provided that the Reporting Person has continued to provide services to the Company through the vesting date.

Remarks:

Princ. Exec. Officer & Chief Comm. Officer